GAA
ABCL icon

Green Alpha Advisors’s AbCellera Biologics ABCL Stock Holding History

Green Alpha Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Sell
21,916
-1,028
-4% -$5.03K 0.12% 104
2026
Q1 		$80.1K Sell
22,944
-4,648
-17% -$16.7K 0.08% 104
2025
Q4 		$94.4K Buy
27,592
+4,817
+21% +$21.5K 0.09% 112
2025
Q3 		$115K Sell
22,775
-6,328
-22% -$27.9K 0.11% 96
2025
Q2 		$99.8K Sell
29,103
-8,347
-22% -$20.8K 0.1% 103
2025
Q1 		$83.5K Sell
37,450
-385
-1% -$1.1K 0.09% 105
2024
Q4 		$111K Sell
37,835
-10,680
-22% -$29.7K 0.09% 141
2024
Q3 		$126K Buy
48,515
+23,806
+96% +$66K 0.1% 132
2024
Q2 		$73.1K Sell
24,709
-3,638
-13% -$13.8K 0.06% 135
2024
Q1 		$128K Buy
28,347
+520
+2% +$2.65K 0.09% 140
2023
Q4 		$159K Sell
27,827
-11,537
-29% -$53.5K 0.11% 148
2023
Q3 		$181K Sell
39,364
-15,051
-28% -$91.6K 0.14% 145
2023
Q2 		$352K Buy
54,415
+6,672
+14% +$45.5K 0.23% 122
2023
Q1 		$360K Sell
47,743
-950
-2% -$8.63K 0.25% 120
2022
Q4 		$493K Sell
48,693
-451
-0.9% -$5.21K 0.41% 97
2022
Q3 		$486K Sell
49,144
-447
-0.9% -$4.9K 0.41% 109
2022
Q2 		$528K Buy
49,591
+15,578
+46% +$132K 0.12% 125
2022
Q1 		$332K Buy
34,013
+5,846
+21% +$55.4K 0.22% 123
2021
Q4 		$403K Buy
28,167
+3,979
+16% +$60.4K 0.27% 115
2021
Q3 		$485K Buy
+24,188
New +$428K 0.33% 115

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Green Alpha Advisors's ABCL Position: Q2 2026 in Review

Green Alpha Advisors reduced its AbCellera Biologics (ABCL) stake by 4.5% in Q2 2026, selling an estimated $5.03K and leaving 21,916 shares worth $172K. The position accounts for 0.12% of the portfolio, ranked #104.

Green Alpha Advisors first reported a position in ABCL in Q3 2021 and has held it in 20 quarters since. The position peaked at $528K in Q2 2022. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Green Alpha Advisors held 21,916 shares of AbCellera Biologics worth $172K as of Q2 2026.
  • Green Alpha Advisors sold 1,028 AbCellera Biologics shares in Q2 2026, an estimated $5.03K.
  • AbCellera Biologics made up 0.12% of Green Alpha Advisors's portfolio in Q2 2026, its #104 holding.
  • Green Alpha Advisors first reported a position in AbCellera Biologics in Q3 2021 and has held it in 20 quarters since.
  • Green Alpha Advisors's AbCellera Biologics position peaked at $528K in Q2 2022.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.